Genes Tech Group Holdings Management
Management criteria checks 4/4
Genes Tech Group Holdings' CEO is Ming-Hsiang Yang, appointed in Dec 2009, has a tenure of 15.17 years. total yearly compensation is NT$6.04M, comprised of 67.6% salary and 32.4% bonuses, including company stock and options. directly owns 3.8% of the company’s shares, worth HK$3.08M. The average tenure of the management team and the board of directors is 10.5 years and 7.7 years respectively.
Key information
Ming-Hsiang Yang
Chief executive officer
NT$6.0m
Total compensation
| CEO salary percentage | 67.6% |
| CEO tenure | 15.2yrs |
| CEO ownership | 3.8% |
| Management average tenure | 10.5yrs |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
Why Investors Shouldn't Be Surprised By Genes Tech Group Holdings Company Limited's (HKG:8257) 32% Share Price Plunge
Nov 20
Genes Tech Group Holdings (HKG:8257) Could Be Struggling To Allocate Capital
Nov 14Lacklustre Performance Is Driving Genes Tech Group Holdings Company Limited's (HKG:8257) Low P/S
Oct 03Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Aug 20Genes Tech Group Holdings (HKG:8257) Has More To Do To Multiply In Value Going Forward
Jun 05There's No Escaping Genes Tech Group Holdings Company Limited's (HKG:8257) Muted Revenues Despite A 27% Share Price Rise
Jun 05Improved Revenues Required Before Genes Tech Group Holdings Company Limited (HKG:8257) Stock's 37% Jump Looks Justified
Apr 17Returns On Capital Are Showing Encouraging Signs At Genes Tech Group Holdings (HKG:8257)
Feb 22Improved Revenues Required Before Genes Tech Group Holdings Company Limited (HKG:8257) Shares Find Their Feet
Dec 20Why We Like The Returns At Genes Tech Group Holdings (HKG:8257)
Oct 19Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Sep 08Returns On Capital Are A Standout For Genes Tech Group Holdings (HKG:8257)
Jul 11Does Genes Tech Group Holdings (HKG:8257) Have A Healthy Balance Sheet?
May 19Calculating The Fair Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Mar 01Genes Tech Group Holdings (HKG:8257) Might Be Having Difficulty Using Its Capital Effectively
Dec 27Estimating The Intrinsic Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Nov 30These 4 Measures Indicate That Genes Tech Group Holdings (HKG:8257) Is Using Debt Extensively
Oct 21Returns On Capital At Genes Tech Group Holdings (HKG:8257) Paint A Concerning Picture
Sep 06Genes Tech Group Holdings' (HKG:8257) Returns On Capital Not Reflecting Well On The Business
May 26Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Apr 13Genes Tech Group Holdings (HKG:8257) Has Some Way To Go To Become A Multi-Bagger
Feb 09Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Nov 26We Think Shareholders Will Probably Be Generous With Genes Tech Group Holdings Company Limited's (HKG:8257) CEO Compensation
Jun 18Returns On Capital At Genes Tech Group Holdings (HKG:8257) Have Stalled
May 26Why Genes Tech Group Holdings Company Limited (HKG:8257) Is A Dividend Rockstar
Apr 08Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Mar 18Returns On Capital - An Important Metric For Genes Tech Group Holdings (HKG:8257)
Feb 23Is Genes Tech Group Holdings Company Limited's(HKG:8257) Recent Stock Performance Tethered To Its Strong Fundamentals?
Jan 19A Look At The Intrinsic Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Dec 16
Will Genes Tech Group Holdings (HKG:8257) Repeat Its Return Growth Of The Past?
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | NT$53m |
| Mar 31 2024 | n/a | n/a | NT$81m |
| Dec 31 2023 | NT$6m | NT$4m | NT$91m |
| Sep 30 2023 | n/a | n/a | -NT$109m |
| Jun 30 2023 | n/a | n/a | -NT$77m |
| Mar 31 2023 | n/a | n/a | -NT$75m |
| Dec 31 2022 | NT$1m | NT$4k | -NT$80m |
| Sep 30 2022 | n/a | n/a | NT$111m |
| Jun 30 2022 | n/a | n/a | NT$106m |
| Mar 31 2022 | n/a | n/a | NT$72m |
| Dec 31 2021 | NT$5m | NT$4m | NT$79m |
| Sep 30 2021 | n/a | n/a | NT$111m |
| Jun 30 2021 | n/a | n/a | NT$95m |
| Mar 31 2021 | n/a | n/a | NT$118m |
| Dec 31 2020 | NT$5m | NT$4m | NT$144m |
| Sep 30 2020 | n/a | n/a | NT$153m |
| Jun 30 2020 | n/a | n/a | NT$164m |
| Mar 31 2020 | n/a | n/a | NT$202m |
| Dec 31 2019 | NT$5m | NT$4m | NT$179m |
| Sep 30 2019 | n/a | n/a | NT$161m |
| Jun 30 2019 | n/a | n/a | NT$132m |
| Mar 31 2019 | n/a | n/a | NT$89m |
| Dec 31 2018 | NT$5m | NT$3m | NT$56m |
Compensation vs Market: Ming-Hsiang's total compensation ($USD184.21K) is about average for companies of similar size in the Hong Kong market ($USD229.71K).
Compensation vs Earnings: Ming-Hsiang's compensation has been consistent with company performance over the past year.
CEO
Ming-Hsiang Yang (53 yo)
15.2yrs
Tenure
NT$6,037,000
Compensation
Mr. Ming-Hsiang Yang serves as Chairman of Genes Tech Group Holdings Company Limited and has been its Chief Executive Officer since December 2009. Prior to joining the Group, Mr. Yang worked in Chung Mei P...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 15.2yrs | NT$6.04m | 3.8% HK$ 3.1m | |
| CFO, Compliance Officer | 13.9yrs | NT$5.64m | 2.91% HK$ 2.4m | |
| Executive Director | less than a year | no data | 0.24% HK$ 198.5k | |
| Company Secretary | 7yrs | no data | no data |
10.5yrs
Average Tenure
53yo
Average Age
Experienced Management: 8257's management team is seasoned and experienced (10.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.7yrs | NT$6.04m | 3.8% HK$ 3.1m | |
| CFO, Compliance Officer | 8.6yrs | NT$5.64m | 2.91% HK$ 2.4m | |
| Executive Director | less than a year | no data | 0.24% HK$ 198.5k | |
| Independent Non-Executive Director | 7.7yrs | NT$954.00k | no data | |
| Independent Non-Executive Director | 7.7yrs | NT$954.00k | no data | |
| Independent Non-Executive Director | 7.7yrs | NT$954.00k | no data |
7.7yrs
Average Tenure
49.5yo
Average Age
Experienced Board: 8257's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 21:02 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genes Tech Group Holdings Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.